GL1X · GenesisL1 explorer

Research workbench

Mycf mycinamicin III 3'-O-methyltransferase (E35Q, E139A variant) in complex with mg, sah and mycinamicin IV (product)

Analyse Mycf mycinamicin III 3'-O-methyltransferase (E35Q, E139A variant) in complex… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4X7V
Type
protein
Length
504 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Mycinamicin III 3''-O-methyltransferase
EC
2.1.1.237
UniProt
Q49492
Ligands
SAH, MIV, MG
Pockets
2 · best druggability 0.76

Structure

x-ray diffraction · 1 distinct chain · 40% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BMycinamicin III 3''-O-methyltransferase (EC 2.1.1.237)protein25240% helix, 16% strandQ49492

Ligands and binding sites

  • SAH · S-adenosyl-L-homocysteine · ligand · 2 copies · chains A, B
  • MIV · Mycinamicin IV · ligand · 2 copies · chains A, B
  • MG · Magnesium ion · metal · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14320.760.8566SAH, MIV
24340.760.8555SAH, MIV

Interfaces

1 interface between chains.

  • A–B · 1095 Ų buried · 12 hydrogen bonds · protein-protein

Compared structures

  • 4X7V · MycF mycinamicin III 3'-O-methyltransferase (E35Q, E139A variant) in complex with Mg, SAH… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q49492 · AlphaFold monomer V2.0 prediction for mycinamicin III 3''-O-methyltransferase (Q49492) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.